We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+26.08%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.1B
AUM Growth
-$548M
Cap. Flow
-$602M
Cap. Flow %
-54.6%
Top 10 Hldgs %
49.57%
Holding
209
New
19
Increased
29
Reduced
24
Closed
40

Top Sells

Rank Stock Value
1
QURE icon
uniQure
QURE
+$15M
2
TRVG
trivago
TRVG
+$11.8M
3
ADNT icon
Adient
ADNT
+$11.5M
4
TRUE
TrueCar
TRUE
+$10.9M
5
PTE
PolarityTE, Inc. Common Stock
PTE
+$9.19M

Sector Composition

Rank Sector Weight
1 Healthcare 24.5%
2 Consumer Discretionary 12.06%
3 Financials 6.3%
4 Communication Services 5.77%
5 Utilities 4.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMCI
51
DELISTED
Navios Maritime Containers L.P. Common Units
NMCI
$4.92M 0.45%
2,057,185
+94,986
+5% +$242K
FENC icon
52
Fennec Pharmaceuticals
FENC
$332M
$4.71M 0.43%
971,351
MDCO
53
DELISTED
Medicines Co
MDCO
$4.67M 0.42%
167,252
SBBP
54
DELISTED
Strongbridge Biopharma plc.
SBBP
$4.23M 0.38%
848,700
TGTX icon
55
TG Therapeutics
TGTX
$7.96B
$4.22M 0.38%
525,000
+25,000
+5% +$135K
FBRX icon
56
Forte Biosciences
FBRX
$1.57B
$4.08M 0.37%
1,000
SRRA
57
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$3.96M 0.36%
57,829
+3,488
+6% +$224K
AMR icon
58
Alpha Metallurgical Resources
AMR
$1.74B
$3.86M 0.35%
66,625
SQBG
59
DELISTED
Sequential Brands Group, Inc.
SQBG
$3.84M 0.35%
74,952
-8,953
-11% -$407K
TCON
60
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$3.75M 0.34%
13,695
LRMR icon
61
Larimar Therapeutics
LRMR
$397M
$3.66M 0.33%
111,259
-5,408
-5% -$277K
NOV icon
62
NOV
NOV
$6.93B
$3.46M 0.31%
130,000
XRT icon
63
PUT
State Street SPDR S&P Retail ETF
XRT
$449M
$3.38M 0.31%
75,000
-225,000
-75% -$10M
RACE icon
64
PUT
Ferrari
RACE
$69.2B
$3.35M 0.3%
25,000
-315,000
-93% -$38.6M
IRCP
65
DELISTED
IRSA Propiedades Comerciales S.A.
IRCP
$3.31M 0.3%
685,911
+376,456
+122% +$1.89M
TWNKW
66
DELISTED
Hostess Brands, Inc. Warrants
TWNKW
$3.28M 0.3%
2,520,000
TRAW icon
67
Traws Pharma
TRAW
$6.85M
$3.19M 0.29%
2,578
ADMA icon
68
ADMA Biologics
ADMA
$1.96B
$3.05M 0.28%
805,000
ARDX icon
69
Ardelyx
ARDX
$1.22B
$2.9M 0.26%
1,036,404
+129,290
+14% +$336K
OTIC
70
DELISTED
Otonomy, Inc.
OTIC
$2.89M 0.26%
1,100,000
ZGNX
71
DELISTED
Zogenix, Inc.
ZGNX
$2.75M 0.25%
50,000
GGAL icon
72
Galicia Financial Group
GGAL
$7.99B
$2.68M 0.24%
105,000
AGRO icon
73
Adecoagro
AGRO
$1.44B
$2.41M 0.22%
350,000
DHT icon
74
DHT Holdings
DHT
$2.99B
$2.3M 0.21%
515,000
+50,000
+11% +$214K
ADVM
75
DELISTED
Adverum Biotechnologies
ADVM
$1.9M 0.17%
36,239

Similar funds

683 Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, 683 Capital Management held 209 positions worth $1.1B, down 33% from $1.65B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

683 Capital Management withdrew a net $602M in Q1 2019, closing 40 positions and reducing 24 holdings. Its most notable exit was PolarityTE, Inc. Common Stock, an estimated $9.19M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, 683 Capital Management opened a new position in Zillow worth $1.71M.

  • 683 Capital Management's largest Q1 2019 buy was Zillow: 50,000 shares worth $1.71M.
  • 683 Capital Management added most to PG&E in Q1 2019, an estimated $31.1M increase.
  • 683 Capital Management's biggest Q1 2019 reduction was uniQure, cutting an estimated $15M.
  • 683 Capital Management fully exited PolarityTE, Inc. Common Stock in Q1 2019, selling an estimated $9.19M.
  • 683 Capital Management's ten largest holdings make up 50% of its $1.1B portfolio in Q1 2019.
  • 683 Capital Management opened 19 new positions and closed 40 in Q1 2019.
  • 683 Capital Management's portfolio value fell 33% quarter-over-quarter to $1.1B.

Based on 683 Capital Management's 13F filing for Q1 2019, filed 15 May 2019.